Physicians need clear data to safely prescribe biosimilar medications.

Under many health plans, only the sickest can receive the cure they need.

It’s a small price to pay for patient safety.

Are insurers cost-shifting policies pricing cancer patients out of care?

Breakthrough therapies offer millions of Americans with hepatitis the long-awaited chance for a cure. But complex prior authorization requirements make accessing these cures difficult –

Lengthy prior authorization processes delay patient access to vital medications.

The difference between a long-shot and a moon-shot.

Without Access, Abuse-Deterrent Pain Medications Can’t Help the Patients Who Need Them

Safer options for treating surgical pain.